Article Text

Download PDFPDF
P06 Estimating the disability adjusted life years directly associated with SARS-CoV-2 (Covid-19) in the republic of Ireland: the first full year
  1. Declan Moran1,
  2. Sara Monteiro Pires2,
  3. Grant Wyper3,
  4. Brecht Devleesschauwer4,5,
  5. Sarah Cuschieri6,
  6. Zubair Kabir1
  1. 1School of Public Health, University College Cork, Cork, Ireland
  2. 2National Food Institute, Technical University of Denmark, Lyngby, Denmark
  3. 3Place and Wellbeing Directorate, Public Health Scotland, Glasgow, UK
  4. 4Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium
  5. 5Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium
  6. 6Faculty of Medicine and Surgery, University of Malta, Msida, MSD 2080, Malta


Background By March 2020, COVID-19 cases were confirmed globally. Internationally, variations in estimates relating to the ‘direct’ effect of COVID-19 on population health have been reported. The key to standardising comparisons between nations is to quantify the total effect of COVID-19’s morbidity and mortality, using a standardised methodology. The Burden of Disease (BoD) frameworks achieve this using a summary metric, the ‘Disability-Adjusted- Life- Years’ (DALYs).

Methods Our DALYs are estimates of summing the ‘Years-of-Life-Lost’ (YLLs) and the ‘Years- Lost due to Disability’ (YLD) for the ‘direct’ burden of COVID-19 in the Republic of Ireland (RoI) from March 01, 2020, to February 28, 2021. Life expectancy was based on the Global Burden of Disease (GBD) Study life tables for 2019.

Results There were 220,273 cases of COVID-19 and 4,500 related deaths within this study’s parameters. DALYs were estimated to be 51,532.1 (95% Uncertainty Intervals [UI] 50,671.6, 52,294.3). Overall, YLL contributed to 98.7% of the DALYs. Of total symptomatic cases, 6.5% required hospitalisation and of those hospitalised 10.8% required intensive care unit treatment. COVID-19 was likely to be the second highest cause of death over our study’s duration.

Conclusion Estimating the burden of a disease at national level is useful for comparing its impact with other diseases in the population and across populations. This work sets out to standardise a COVID-19 BoD methodology framework for the RoI and comparable nations in the EU.

  • COVID-19
  • Burden
  • Ireland

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.